MILAN, JULY 24 – Milan is the Italian candidate to host the new headquarters of the European Medicines Agency (EMA) which, in the aftermath of Brexit, will have to leave its current offices in London by March 2019. Prime Minister Gentiloni, the President of the Regional Council of Lombardy Maroni and the Mayor of Milan Giuseppe Sala launched the effort on Monday from on the 31st floor of the Pirelli Tower.
With the Milan candidacy, Italy offers to the European Union a new headquarters perfectly capable of assuring continuity to the operations of EMA, an Agency that is strategically relevant for protecting the health of 500 million European citizens through the responsibility it holds to authorise the launch of new prescription drugs on the market. The immediate availability of the Pirelli Tower, which is publicly owned and can be easily reconverted to accommodate the needs of the EMA is a point of strength of Milan’s candidacy.
The adjudication process envisages several steps and will end with a simple majority vote for the progressive elimination of candidates (in a maximum of three voting sessions), to be held at the General Affairs Council meeting of 20 November.
According to a note published on the Ministry of Foreign Affairs website, Italy is convinced that, despite the competition of numerous European cities, it disposes of a highly competitive and prestigious candidacy, carefully prepared over the last few months through a national Situation Room managed by the Advisor to the Prime Minister for the promotion of relocating the European Medicines Agency in Milan, Prof Enzo Moavero Milanesi, with the participation of the Ministries of Foreign Affairs and International Cooperation, of the Interior, of Economy and Finance, of Education, University and Research, of Health and of the Regional Council of Lombardy and the Municipal Council of Milan.
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) located in London. It began operating in 1995. The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
Serving a market of over 500 million people, EMA protects public and animal health in 28 EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality. EMA is committed to enabling timely patient access to new medicines, and plays a vital role in supporting medicine development for the benefit of patients. The Agency uses a wide range of regulatory mechanisms to achieve these aims, which are continuously reviewed and improved.
Also called “Pirellone”, literally “Big Pirelli”, the proposed headquarters is a 32-storey, 124.1 m (407 ft) skyscraper. The building, developed by architect Gio Ponti, with the assistance of Pier Luigi Nervi and Arturo Danusso, was the inspiration for the design of the Pan Am Building (now MetLife Building) in New York. (@OnuItalia)